Between the Biotech Waves
Between the Biotech Waves—discussing recent developments and market dynamics impacting the biotech sector.
Between the Biotech Waves
Episode 32: The Triplet Therapeutics story, from concept to birth, life & death.
•
Nessan Bermingham PhD
•
Season 1
•
Episode 32
Today we have an unusual (& long) podcast where we talk to key members of the Triplet Therapeutics management team. Triplet was founded to develop antisense oligonucleotides targeting the DNA damage response pathway that has been implicated in driving repeat disorders including Huntington's disease - the lead indication for Triplet. The team discusses the challenges in building the company and what ultimately led to it's demise.
